Clinical trial
Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients
NCT01414842 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Lecco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients
- Lead sponsor
- Azienda Ospedaliera di Lecco
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- December 31, 2008
- Enrollment
- 50 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.